Correlation Between Blueprint Medicines and Immunovant
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Immunovant, you can compare the effects of market volatilities on Blueprint Medicines and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Immunovant.
Diversification Opportunities for Blueprint Medicines and Immunovant
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Blueprint and Immunovant is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Immunovant go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Immunovant
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 1.21 times less return on investment than Immunovant. But when comparing it to its historical volatility, Blueprint Medicines Corp is 1.66 times less risky than Immunovant. It trades about 0.06 of its potential returns per unit of risk. Immunovant is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,462 in Immunovant on August 28, 2024 and sell it today you would earn a total of 1,227 from holding Immunovant or generate 83.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Immunovant
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Immunovant |
Blueprint Medicines and Immunovant Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Immunovant
The main advantage of trading using opposite Blueprint Medicines and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |